Apolo V Acquisition Corp. (TSXV: AFV.P) (“Apolo V” or the “Company”) and TelyRx, Inc. (“TelyRx”), a vertically integrated technology enabled healthcare and pharmacy services company, are pleased to announce they have entered into a business combination agreement dated January 19, 2026 (the “Business Combination Agreement”), among others, to complete a go-public transaction for TelyRx (the “Proposed Transaction”) that will constitute Apolo V’s “Qualifying Transaction” (the “Qualifying Transaction”) under Policy 2.4 – Capital Pool Companies of the TSX Venture Exchange (the “TSXV”).
Read the full article: Apolo V Acquisition Corp. Enters into Definitive Agreement with Telyrx, Inc. //
Source: https://finance.yahoo.com/news/apolo-v-acquisition-corp-enters-214200371.html